Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.
about
Anti-inflammatory preconditioning by agonists of adenosine A1 receptorMolecular action of methotrexate in inflammatory diseasesRegulation of neutrophil function by adenosine.Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutionsRegulation generation: the suppressive functions of human regulatory T cellsAdenosine A2A agonists in development for the treatment of inflammationGenetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient miceNOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion InjuryActivation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils.The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.Effects of adenosine A₂A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice.Adenosine deaminase inhibition prevents Clostridium difficile toxin A-induced enteritis in mice.Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology.Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury.A novel neutrophil-specific PET imaging agent: cFLFLFK-PEG-64Cu.The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cellsReduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist.Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinaseResolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction.Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A(2A) receptor activation.Stimulation of A2A-adenosine receptors after myocardial infarction suppresses inflammatory activation and attenuates contractile dysfunction in the remote left ventricle.Phosphorylation of P-Rex1 by the cyclic AMP-dependent protein kinase inhibits the phosphatidylinositiol (3,4,5)-trisphosphate and Gbetagamma-mediated regulation of its activity.Differential sensitivity of P-Rex1 to isoforms of G protein betagamma dimers.Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils.Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction.An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis modelsAdenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritisAdenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsPurinergic receptors in gastrointestinal inflammation.Cardioprotection of controlled and cardiac-specific over-expression of A(2A)-adenosine receptor in the pressure overloadA role for the low-affinity A2B adenosine receptor in regulating superoxide generation by murine neutrophilsAdenosine receptor agonists: from basic medicinal chemistry to clinical development.The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway.
P2860
Q21144315-FCA8A381-9D89-43A4-BA64-1E9223BB452CQ24534771-013F15BF-BEEB-4890-A784-CA504C8DA3A7Q24620317-677235C9-D2CA-4A51-925B-262AE2EFCBDCQ24644038-102F6E4C-1B94-40FA-900B-8D2981E1A127Q26823216-F29770F2-8604-42B2-8503-D7A2E6E6766AQ28261970-B8CBBFD4-2981-40D4-8675-DD8846CF079BQ28512453-A5023CF2-6391-4CE3-9717-F360DC7418A5Q30277768-3FEFE518-D7D7-4EFA-AD49-3315CB32D107Q30311882-2121257A-53E2-4C09-B73A-2890B58C14D5Q30409961-AE552F75-66C8-47C0-9C5B-EE4C128B7BBDQ30423298-D7C7F7B6-84E7-4D0B-A9BE-00C6B9AE74E9Q30427422-92EB275D-DF57-4F2D-ACDE-DB944CCAD62EQ30431245-07530C7E-AFB0-4FF3-834E-6C209BD7D120Q30433245-105A8D99-EBCA-4148-A0C1-52866F40D5EEQ30433358-9B4DF4B4-89C7-4E1C-AE42-394FBBFBF135Q30433846-D094E626-E770-4DDE-8493-A1DCA33301BDQ30434114-9EB07BB1-63E3-464D-A3ED-1BABF824D537Q30435260-D871B969-1347-4A28-A11C-B510FD1321C0Q30435373-92953269-E446-4195-815D-265B6818CBEAQ30435403-A6E2EC77-1FF2-485A-B028-1A851D9CBFA0Q30437086-1ABF8CC6-5CD7-4F10-9AAF-C07CE9236301Q30437433-A83462A0-CDE8-4744-B8A0-26AC7E0D7CE6Q30438077-A21A83C8-E03D-4568-9814-6FCFB98EE9D8Q30438669-2FF528E6-5074-44D5-82E8-D63B2EDB5A7EQ30438741-33F8A0B0-CA53-4940-835E-F66C099CF098Q30438744-9B0A32AE-B0EF-4F83-B377-FB38B1F70ABEQ30438821-B6118560-33EE-47D1-B86F-213089961C95Q30438880-9FF80144-0322-4EBA-9EFF-213D08289489Q30440124-B1AC51E3-E5F0-4799-9BD8-5C3405C7071CQ30440768-371B996B-262D-4937-87D5-D2AC7CD01740Q30442067-FB46911D-A5A2-43F0-A219-728A32488F33Q30442968-44FAADED-2EAD-4C1F-BC24-3A5EA7C7BBA1Q30446178-677A60AC-6762-4098-ADA9-6343419B35DEQ30450509-5519064F-99C2-4E18-9A65-3E69F7B8784DQ30486707-F9BDB51C-89D2-4DEA-86B7-EF725BC52840Q34008598-E2B5B76D-7001-4353-A4BD-F4361C82612AQ34335762-58BD4309-A051-4FD3-B3D5-7FE713014CD8Q35188154-2E4A17DE-C255-4CE2-9C45-3E31151BEC2CQ35602688-710CB4D5-539A-47DE-9487-E3B449605346Q35781777-B74DBBDF-5ADE-4BAB-BEF0-C0F32F94724B
P2860
Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cyclic AMP-dependent inhibitio ...... nosine A(2A) receptor agonists
@nl
Cyclic AMP-dependent inhibitio ...... osine A(2A) receptor agonists.
@ast
Cyclic AMP-dependent inhibitio ...... osine A(2A) receptor agonists.
@en
type
label
Cyclic AMP-dependent inhibitio ...... nosine A(2A) receptor agonists
@nl
Cyclic AMP-dependent inhibitio ...... osine A(2A) receptor agonists.
@ast
Cyclic AMP-dependent inhibitio ...... osine A(2A) receptor agonists.
@en
prefLabel
Cyclic AMP-dependent inhibitio ...... nosine A(2A) receptor agonists
@nl
Cyclic AMP-dependent inhibitio ...... osine A(2A) receptor agonists.
@ast
Cyclic AMP-dependent inhibitio ...... osine A(2A) receptor agonists.
@en
P2093
P2860
P356
P1476
Cyclic AMP-dependent inhibitio ...... osine A(2A) receptor agonists.
@en
P2093
G W Sullivan
J M Rieger
T L Macdonald
W M Scheld
P2860
P304
P356
10.1038/SJ.BJP.0703893
P407
P577
2001-03-01T00:00:00Z